Quarter of patients have subsequent surgery after breast conservation surgery

November 12, 2014

Nearly a quarter of all patients who underwent initial breast conservation surgery (BCS) for breast cancer had a subsequent surgical intervention, according to a report published online by JAMA Surgery.

Completely removing breast cancer is seen as the best way to reduce recurrence and improve survival. A lack of consensus on an adequate margin width has led to variable rates of reexcision and, as a result, patients undergo repeat or additional surgeries, according to background information provided in the study.

Lee G. Wilke, M.D., of the University of Wisconsin School of Medicine and Public Health, Madison, and fellow co-authors looked at patient, tumor and facility factors that influenced repeat surgery rates in U.S. patients undergoing BCS from 2004 through 2010. The authors' study included 316,114 patients with diagnosed breast cancer (stage 0 to II) who had initial BCS. Patients initially treated with chemotherapy to shrink their tumors (neoadjuvantly treated) or those who were diagnosed by excisional biopsy were excluded.

The study found 241,597 patients (76.4 percent) underwent a single lumpectomy and 74,517 patients (23.6 percent) had at least one additional operation. Of the patients who had an additional operation, 46,250 (62.1 percent) had a completion lumpectomy and 28,267 (37.9 percent) underwent mastectomy. The proportion of patients undergoing repeat surgery decreased during the study period from 25.4 percent to 22.7 percent. Tumor size and histologic subtype were the two most notable patient factors associated with repeat surgeries. Academic research facilities had a 26 percent repeat surgery rate compared with a 22.4 percent rate at community facilities. Facilities in the Mountain region of the U.S. were less likely to perform repeat surgery compared with facilities in the Northeast (18.4% and 26.5% respectively).

"These findings can be used by surgeons to better inform patients regarding repeat surgery rates and how patient or tumor characteristics influence these rates. More important, these data can be used to further support the vitally important adoption of guidelines regarding reexcision after initial BCS. Standard definitions of adequate margins as set forth in the consensus guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology and the indications for reexcision will decrease the wide variation in repeat surgery rates and decrease costs and patient anxiety surrounding tumor-positive margins," the authors conclude.

(JAMA Surgery. Published online November 12, 2014. doi:10.1001/jamasurg.2014.926. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Commentary: Breast Conservation Surgery, Definition of Adequate Margins

In a related commentary, Julie A. Margenthaler, M.D., Washington University School of Medicine, St. Louis, and Aislinn Vaughan, M.D., of the Sisters of St. Mary's Breast Care, St. Charles, Mo., write: "The Society of Surgical Oncology and the American Society for Radiation Oncology developed a consensus statement, supported by systematic review data, encouraging adoption of 'no tumor on ink' as the standard definition of a negative margin for invasive stage I and II breast cancer. It is time to put our biases aside. We have robust evidence that additional operations for close, but negative, margins do not result in better outcomes."

"However, additional operations increase health care costs, misuse of resources, patient anxiety and delay in adjuvant therapy. With more than 200,000 new invasive breast cancers diagnosed each year, a staggering number of women are undergoing procedures that are unnecessary and simply wasteful. Our hope is that the Society of Surgical Oncology and the American Society for Radiation Oncology guidelines will be rapidly adopted by surgeons. Data from the study by Wilke et al will provide an excellent historical reference for future investigation of the success of this paradigm shift," the authors conclude.

(JAMA Surgery. Published online November 12, 2014. doi:10.1001/jamasurg.2014.950. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Media Advisory: To contact author Lee G. Wilke, M.D., call Susan L. Smith at 608-890-5643 or email SSmith5@uwhealth.org. To contact corresponding commentary author Julie A. Margenthaler, M.D., call Jim Goodwin at 314-286-0166 or email Jgoodwin@wustl.edu.

The JAMA Network Journals

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.